Orshe

New research on red meat shows that eating steak is okay, just hold off on the sausages and bacon. WSJ’s Ron Winslow discusses.

View original here:  News Hub: Reach for the Steak, Skip the Dog/a>

WSJ Health & Sciences deputy bureau chief Ron Winslow discusses a new kind of implantable defibrillator in a conversation with Lee Hawkins.

Originally posted here:  New Defibrillator Avoids Wires in Heart/a>

WSJ’s relationships columnist Elizabeth Bernstein offers a few tips on how to properly deliver a compliment.

View original here: How Not to Give a Compliment/a>

A federal judge’s ruling earlier this week that some patents on human genes are invalid because they were related to isolated DNA “found in nature” is being watched closely by other holders of such patents of human genes. (Read more from the WSJ about the case.)

The genes in dispute involve BRCA1 and BRCA2, two genes that many geneticists say are particularly important because they are such powerful markers for diagnosing risk of a hereditary form of breast cancer.

WSJ’s health columnist Melinda Beck tests out acupuncture as an alternative means to reduce her neck and back pain.

Read the original post: Testing Acupuncture/a>

The Orphan Drug Act has been around since 1983 offering tax incentives and competition protection for drugs aimed at treating rare diseases. But there have been relatively few orphan drugs developed, so the FDA is beating the bushes for more participation.

A new pill-container top called a “GlowCap” is equipped with a wireless transmitter that notifies patients when it’s time to take their medicine. WSJ’s Anna Mathews explains how it works.

Read the original: Digits: Beep! Time to Take Your Medicine/a>

And speaking of the health-overhaul proposals (see previous post), we note an armful of stories today dealing with what has become a third-rail issue — the rates at which premiums are going up for individual health plans.

Paper medical records can easily go missing, contain bad or missing information and undermine patient care. But consider the alternative, says Alexander Friedman, a fellow in maternal-fetal medicine at the University of Pennsylvania.

Billy Tauzin — the former Louisiana congressman who stuck with the homespun phrases even as he pulled down $2 million a year to represent the drug industry in DC — is stepping down as the head of PhRMA, the big trade group.

The WSJ notes that he was criticized “for his support of the White House’s now-teetering plan to overhaul health care.”